MELISSA PERSAUD: Open Payments
NPI 1649681875 · MINEOLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,967 in 52 payments from 11 companies in 2025. Trend: 2023 $774 · 2024 $1,323 · 2025 $1,967
Food & beverage: $1,967
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $490 |
| Phathom Pharmaceuticals, Inc. | 5 | $246 |
| GENZYME CORPORATION | 4 | $207 |
| Regeneron Healthcare Solutions, Inc. | 5 | $178 |
| Janssen Biotech, Inc. | 4 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $138 |
| Lilly USA, LLC | 1 | $125 |
| Amgen Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $102 |
Products named: DUPIXENT, VOQUEZNA, RINVOQ, TREMFYA, ENTYVIO, XIFAXAN, OMVOH, UPLIZNA.
Industry payments across NY — which companies pay providers there.
